Jazz Pharmaceuticals plc - 8-K Filing

Jazz Pharmaceuticals shareholders approved six proposals at the 2026 annual general meeting with over 90% voting in favor of each. (Items: 5.07 Submission of Matters to a Vote of Security Holders)

SEC EDGAR ·

Tickers: $JAZZ

Read the full article at SEC EDGAR

More Regulatory news